Theralink Technologies, Inc. (THER)
THER Stock Price Chart
Explore Theralink Technologies, Inc. interactive price chart. Choose custom timeframes to analyze THER price movements and trends.
THER Company Profile
Discover essential business fundamentals and corporate details for Theralink Technologies, Inc. (THER) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
1 Apr 2010
Employees
16.00
Website
https://theralink.comCEO
Michael I. Ruxin
Description
Theralink Technologies, Inc., a commercial-stage precision medicine and molecular data-generating company, engages in the development and commercialization of novel cancer immunotherapy products. The company through its patented phosphoprotein and protein biomarker platform, and laboratory developed test technology targets multiple areas of oncology and drug development. It provides precision oncology data through its Theralink Reverse Phase Protein Array assays to assist the biopharmaceutical industry and clinical oncologists in identifying likely responders and non-responders to FDA-approved and investigational drug treatments. The company's data-generating assays provide actionable information for physicians, patients, and biopharmaceutical companies in the area of oncology. Theralink Technologies, Inc. was formerly known as OncBioMune Pharmaceuticals, Inc. and changed its name to Theralink Technologies, Inc. in September 2020. The company is headquartered in Golden, Colorado.
THER Financial Timeline
Browse a chronological timeline of Theralink Technologies, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Earnings released on 3 Jan 2025
Earnings released on 13 Nov 2024
Earnings released on 29 Aug 2024
Earnings released on 20 May 2024
Earnings released on 20 Feb 2024
EPS came in at $0.00 , while revenue for the quarter reached $179.27K .
Earnings released on 27 Dec 2023
Earnings released on 21 Aug 2023
EPS came in at $0.00 , while revenue for the quarter reached $202.45K .
Earnings released on 15 May 2023
EPS came in at $0.00 , while revenue for the quarter reached $202.45K .
Earnings released on 21 Feb 2023
EPS came in at -$0.00 , while revenue for the quarter reached $169.79K .
Earnings released on 29 Dec 2022
EPS came in at -$0.00 , while revenue for the quarter reached $305.22K .
Earnings released on 15 Aug 2022
EPS came in at -$0.00 , while revenue for the quarter reached $164.21K .
Earnings released on 23 May 2022
EPS came in at -$0.00 , while revenue for the quarter reached $19.50K .
Earnings released on 18 Feb 2022
EPS came in at -$0.00 , while revenue for the quarter reached $78.98K .
Earnings released on 13 Jan 2022
EPS came in at -$0.00 , while revenue for the quarter reached $90.58K .
Earnings released on 28 Sept 2021
EPS came in at -$0.00 , while revenue for the quarter reached $278.93K .
Earnings released on 27 Sept 2021
EPS came in at -$0.00 , while revenue for the quarter reached $126.31K .
Earnings released on 27 Sept 2021
EPS came in at -$0.00 , while revenue for the quarter reached $9.79K .
Earnings released on 27 Sept 2021
EPS came in at -$3.43 , while revenue for the quarter reached $105.33K .
Earnings released on 10 Jun 2021
EPS came in at -$2.04 , while revenue for the quarter reached $24.89K .
THER Stock Performance
Access detailed THER performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.